Guyana

Guyana

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.68 (0.57 - 0.79) 2019 Modelled IHME
0.68 (0.57 - 0.78) 2018 Modelled IHME
0.68 (0.56 - 0.78) 2017 Modelled IHME
0.71 (0.60 - 0.82) 2016 Modelled IHME
0.76 (0.63 - 0.90) 2015 Modelled IHME
0.78 (0.65 - 0.92) 2014 Modelled IHME
0.8 (0.67 - 0.93) 2013 Modelled IHME
0.81 (0.68 - 0.93) 2012 Modelled IHME
0.82 (0.69 - 0.95) 2011 Modelled IHME
0.83 (0.69 - 0.97) 2010 Modelled IHME
0.85 (0.71 - 0.97) 2009 Modelled IHME
0.86 (0.72 - 0.98) 2008 Modelled IHME
0.87 (0.73 - 1) 2007 Modelled IHME
0.89 (0.74 - 1.02) 2006 Modelled IHME
0.89 (0.74 - 1.04) 2005 Modelled IHME
0.9 (0.74 - 1.05) 2004 Modelled IHME
0.9 (0.74 - 1.06) 2003 Modelled IHME
0.91 (0.74 - 1.06) 2002 Modelled IHME
0.91 (0.74 - 1.07) 2001 Modelled IHME
0.92 (0.74 - 1.08) 2000 Modelled IHME
0.92 (0.74 - 1.09) 1999 Modelled IHME
0.93 (0.74 - 1.10) 1998 Modelled IHME
0.94 (0.75 - 1.11) 1997 Modelled IHME
0.95 (0.76 - 1.11) 1996 Modelled IHME
0.95 (0.77 - 1.12) 1995 Modelled IHME
0.95 (0.77 - 1.11) 1994 Modelled IHME
0.95 (0.77 - 1.11) 1993 Modelled IHME
0.95 (0.76 - 1.11) 1992 Modelled IHME
0.94 (0.77 - 1.10) 1991 Modelled IHME
0.94 (0.76 - 1.09) 1990 Modelled IHME
2.78 (0.18 - 32.71) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.05 (0.03 - 0.07) 2019 Modelled IHME
0.05 (0.03 - 0.07) 2018 Modelled IHME
0.05 (0.04 - 0.07) 2017 Modelled IHME
0.05 (0.04 - 0.07) 2016 Modelled IHME
0.06 (0.04 - 0.08) 2015 Modelled IHME
0.06 (0.04 - 0.08) 2014 Modelled IHME
0.06 (0.04 - 0.08) 2013 Modelled IHME
0.06 (0.04 - 0.08) 2012 Modelled IHME
0.06 (0.04 - 0.08) 2011 Modelled IHME
0.06 (0.04 - 0.08) 2010 Modelled IHME
0.06 (0.05 - 0.08) 2009 Modelled IHME
0.07 (0.05 - 0.09) 2008 Modelled IHME
0.07 (0.05 - 0.09) 2007 Modelled IHME
0.08 (0.06 - 0.10) 2006 Modelled IHME
0.08 (0.06 - 0.11) 2005 Modelled IHME
0.12 (0.09 - 0.16) 2004 Modelled IHME
0.21 (0.15 - 0.27) 2003 Modelled IHME
0.31 (0.23 - 0.41) 2002 Modelled IHME
0.4 (0.29 - 0.53) 2001 Modelled IHME
0.45 (0.31 - 0.60) 2000 Modelled IHME
0.46 (0.32 - 0.61) 1999 Modelled IHME
0.46 (0.32 - 0.63) 1998 Modelled IHME
0.47 (0.32 - 0.63) 1997 Modelled IHME
0.47 (0.32 - 0.64) 1996 Modelled IHME
0.47 (0.32 - 0.64) 1995 Modelled IHME
0.47 (0.32 - 0.63) 1994 Modelled IHME
0.47 (0.33 - 0.63) 1993 Modelled IHME
0.47 (0.33 - 0.62) 1992 Modelled IHME
0.47 (0.33 - 0.61) 1991 Modelled IHME
0.46 (0.34 - 0.60) 1990 Modelled IHME
0.95 (0.06 - 14.69) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.18 (2.16 - 4.54) 2019 Modelled IHME
3.17 (2.15 - 4.53) 2018 Modelled IHME
3.17 (2.16 - 4.41) 2017 Modelled IHME
3.2 (2.21 - 4.41) 2016 Modelled IHME
3.22 (2.21 - 4.47) 2015 Modelled IHME
3.43 (2.35 - 4.69) 2014 Modelled IHME
3.71 (2.57 - 5.10) 2013 Modelled IHME
4.26 (3.05 - 5.82) 2012 Modelled IHME
4.57 (3.31 - 6.18) 2011 Modelled IHME
4.69 (3.38 - 6.29) 2010 Modelled IHME
4.47 (3.25 - 6.01) 2009 Modelled IHME
4.48 (3.26 - 6.01) 2008 Modelled IHME
4.38 (3.19 - 5.92) 2007 Modelled IHME
4.37 (3.16 - 5.93) 2006 Modelled IHME
4.38 (3.12 - 6.03) 2005 Modelled IHME
4.36 (3.14 - 5.97) 2004 Modelled IHME
4.27 (3.11 - 5.88) 2003 Modelled IHME
4.19 (3.02 - 5.82) 2002 Modelled IHME
3.93 (2.84 - 5.35) 2001 Modelled IHME
3.58 (2.66 - 4.81) 2000 Modelled IHME
4.06 (3 - 5.46) 1999 Modelled IHME
4.26 (3.18 - 5.66) 1998 Modelled IHME
4.46 (3.34 - 5.90) 1997 Modelled IHME
4.71 (3.51 - 6.20) 1996 Modelled IHME
4.63 (3.45 - 6.05) 1995 Modelled IHME
4.57 (3.41 - 6.04) 1994 Modelled IHME
4.63 (3.49 - 6.16) 1993 Modelled IHME
4.46 (3.34 - 5.86) 1992 Modelled IHME
4.59 (3.48 - 5.96) 1991 Modelled IHME
4.84 (3.64 - 6.31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
24 (17 - 35) 2019 Modelled IHME
24 (17 - 35) 2018 Modelled IHME
24 (16 - 34) 2017 Modelled IHME
24 (16 - 33) 2016 Modelled IHME
24 (16 - 33) 2015 Modelled IHME
25 (17 - 35) 2014 Modelled IHME
27 (19 - 38) 2013 Modelled IHME
32 (23 - 43) 2012 Modelled IHME
34 (25 - 46) 2011 Modelled IHME
35 (25 - 47) 2010 Modelled IHME
34 (24 - 45) 2009 Modelled IHME
34 (25 - 45) 2008 Modelled IHME
33 (24 - 45) 2007 Modelled IHME
33 (24 - 45) 2006 Modelled IHME
33 (24 - 46) 2005 Modelled IHME
33 (24 - 46) 2004 Modelled IHME
33 (24 - 45) 2003 Modelled IHME
32 (23 - 45) 2002 Modelled IHME
30 (22 - 41) 2001 Modelled IHME
28 (20 - 37) 2000 Modelled IHME
31 (23 - 42) 1999 Modelled IHME
33 (24 - 43) 1998 Modelled IHME
34 (26 - 45) 1997 Modelled IHME
36 (27 - 47) 1996 Modelled IHME
35 (26 - 46) 1995 Modelled IHME
35 (26 - 46) 1994 Modelled IHME
35 (27 - 47) 1993 Modelled IHME
34 (26 - 45) 1992 Modelled IHME
35 (27 - 46) 1991 Modelled IHME
37 (28 - 49) 1990 Modelled IHME
71 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
28 (21 - 37) 2019 Modelled IHME
28 (21 - 37) 2018 Modelled IHME
28 (21 - 37) 2017 Modelled IHME
28 (21 - 37) 2016 Modelled IHME
28 (22 - 37) 2015 Modelled IHME
29 (22 - 38) 2014 Modelled IHME
29 (22 - 38) 2013 Modelled IHME
30 (23 - 39) 2012 Modelled IHME
30 (23 - 39) 2011 Modelled IHME
31 (24 - 40) 2010 Modelled IHME
31 (24 - 39) 2009 Modelled IHME
31 (24 - 39) 2008 Modelled IHME
31 (23 - 39) 2007 Modelled IHME
31 (23 - 39) 2006 Modelled IHME
31 (23 - 39) 2005 Modelled IHME
31 (23 - 39) 2004 Modelled IHME
31 (23 - 39) 2003 Modelled IHME
31 (23 - 39) 2002 Modelled IHME
31 (23 - 39) 2001 Modelled IHME
31 (24 - 39) 2000 Modelled IHME
31 (24 - 39) 1999 Modelled IHME
31 (23 - 39) 1998 Modelled IHME
31 (23 - 39) 1997 Modelled IHME
30 (23 - 39) 1996 Modelled IHME
30 (23 - 39) 1995 Modelled IHME
30 (23 - 39) 1994 Modelled IHME
30 (23 - 39) 1993 Modelled IHME
30 (23 - 39) 1992 Modelled IHME
30 (23 - 39) 1991 Modelled IHME
30 (23 - 39) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
97 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
95 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
93 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
93 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
93 2006 Survey/reported WHO/UNICEF
93 2005 Survey/reported WHO/UNICEF
91 2004 Survey/reported WHO/UNICEF
90 2003 Survey/reported WHO/UNICEF
91 2002 Survey/reported WHO/UNICEF
85 2001 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.32 (1.87 - 2.88) 2019 Modelled IHME
2.3 (1.86 - 2.85) 2018 Modelled IHME
2.29 (1.84 - 2.85) 2017 Modelled IHME
2.28 (1.84 - 2.82) 2016 Modelled IHME
2.27 (1.82 - 2.78) 2015 Modelled IHME
2.26 (1.82 - 2.80) 2014 Modelled IHME
2.25 (1.82 - 2.80) 2013 Modelled IHME
2.25 (1.82 - 2.78) 2012 Modelled IHME
2.24 (1.81 - 2.78) 2011 Modelled IHME
2.23 (1.80 - 2.79) 2010 Modelled IHME
2.22 (1.79 - 2.77) 2009 Modelled IHME
2.2 (1.77 - 2.74) 2008 Modelled IHME
2.19 (1.76 - 2.72) 2007 Modelled IHME
2.18 (1.75 - 2.69) 2006 Modelled IHME
2.17 (1.73 - 2.68) 2005 Modelled IHME
2.17 (1.73 - 2.69) 2004 Modelled IHME
2.17 (1.73 - 2.69) 2003 Modelled IHME
2.17 (1.73 - 2.70) 2002 Modelled IHME
2.17 (1.74 - 2.68) 2001 Modelled IHME
2.17 (1.74 - 2.70) 2000 Modelled IHME
2.17 (1.74 - 2.72) 1999 Modelled IHME
2.19 (1.76 - 2.74) 1998 Modelled IHME
2.22 (1.78 - 2.76) 1997 Modelled IHME
2.24 (1.79 - 2.80) 1996 Modelled IHME
2.25 (1.79 - 2.81) 1995 Modelled IHME
2.25 (1.80 - 2.81) 1994 Modelled IHME
2.25 (1.80 - 2.80) 1993 Modelled IHME
2.25 (1.80 - 2.79) 1992 Modelled IHME
2.25 (1.81 - 2.80) 1991 Modelled IHME
2.25 (1.80 - 2.83) 1990 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.08 (4.74 - 10.10) 2019 Modelled IHME
7.03 (4.80 - 9.85) 2018 Modelled IHME
7.01 (4.91 - 9.70) 2017 Modelled IHME
7.1 (5.03 - 9.83) 2016 Modelled IHME
7.14 (5.06 - 9.96) 2015 Modelled IHME
7.12 (5.05 - 9.85) 2014 Modelled IHME
6.67 (4.66 - 9.11) 2013 Modelled IHME
6.62 (4.76 - 9.05) 2012 Modelled IHME
6.36 (4.55 - 8.80) 2011 Modelled IHME
6.25 (4.48 - 8.54) 2010 Modelled IHME
5.94 (4.27 - 8.14) 2009 Modelled IHME
5.97 (4.30 - 8.15) 2008 Modelled IHME
5.87 (4.21 - 7.90) 2007 Modelled IHME
5.87 (4.30 - 7.97) 2006 Modelled IHME
5.92 (4.29 - 8) 2005 Modelled IHME
5.89 (4.22 - 7.89) 2004 Modelled IHME
5.77 (4.18 - 7.77) 2003 Modelled IHME
5.65 (4.04 - 7.64) 2002 Modelled IHME
5.29 (3.80 - 7.19) 2001 Modelled IHME
4.77 (3.48 - 6.35) 2000 Modelled IHME
5.41 (3.93 - 7.26) 1999 Modelled IHME
5.63 (4.16 - 7.49) 1998 Modelled IHME
5.82 (4.33 - 7.74) 1997 Modelled IHME
6.04 (4.52 - 7.99) 1996 Modelled IHME
5.91 (4.43 - 7.78) 1995 Modelled IHME
5.84 (4.36 - 7.71) 1994 Modelled IHME
5.95 (4.52 - 7.92) 1993 Modelled IHME
5.8 (4.39 - 7.59) 1992 Modelled IHME
6.05 (4.59 - 7.91) 1991 Modelled IHME
6.39 (4.82 - 8.33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
55 (37 - 77) 2019 Modelled IHME
54 (37 - 76) 2018 Modelled IHME
53 (37 - 74) 2017 Modelled IHME
53 (37 - 73) 2016 Modelled IHME
53 (37 - 73) 2015 Modelled IHME
53 (37 - 73) 2014 Modelled IHME
49 (35 - 67) 2013 Modelled IHME
49 (35 - 67) 2012 Modelled IHME
47 (34 - 65) 2011 Modelled IHME
47 (33 - 64) 2010 Modelled IHME
45 (32 - 61) 2009 Modelled IHME
45 (32 - 61) 2008 Modelled IHME
44 (32 - 60) 2007 Modelled IHME
45 (33 - 60) 2006 Modelled IHME
45 (33 - 61) 2005 Modelled IHME
45 (32 - 60) 2004 Modelled IHME
44 (32 - 60) 2003 Modelled IHME
43 (31 - 59) 2002 Modelled IHME
41 (29 - 55) 2001 Modelled IHME
37 (27 - 49) 2000 Modelled IHME
42 (30 - 56) 1999 Modelled IHME
43 (32 - 58) 1998 Modelled IHME
45 (33 - 59) 1997 Modelled IHME
46 (35 - 61) 1996 Modelled IHME
45 (34 - 60) 1995 Modelled IHME
45 (33 - 59) 1994 Modelled IHME
46 (35 - 61) 1993 Modelled IHME
44 (34 - 58) 1992 Modelled IHME
46 (35 - 61) 1991 Modelled IHME
49 (37 - 64) 1990 Modelled IHME
26 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
21 (15 - 29) 2019 Modelled IHME
21 (15 - 28) 2018 Modelled IHME
21 (15 - 28) 2017 Modelled IHME
21 (15 - 28) 2016 Modelled IHME
21 (15 - 28) 2015 Modelled IHME
21 (15 - 28) 2014 Modelled IHME
21 (15 - 28) 2013 Modelled IHME
21 (15 - 28) 2012 Modelled IHME
21 (15 - 28) 2011 Modelled IHME
21 (15 - 28) 2010 Modelled IHME
21 (15 - 27) 2009 Modelled IHME
21 (14 - 28) 2008 Modelled IHME
21 (14 - 28) 2007 Modelled IHME
21 (14 - 28) 2006 Modelled IHME
21 (14 - 28) 2005 Modelled IHME
21 (14 - 27) 2004 Modelled IHME
21 (14 - 27) 2003 Modelled IHME
20 (14 - 27) 2002 Modelled IHME
20 (14 - 27) 2001 Modelled IHME
20 (14 - 27) 2000 Modelled IHME
20 (14 - 27) 1999 Modelled IHME
20 (14 - 27) 1998 Modelled IHME
20 (14 - 27) 1997 Modelled IHME
20 (14 - 27) 1996 Modelled IHME
21 (14 - 28) 1995 Modelled IHME
21 (15 - 28) 1994 Modelled IHME
21 (14 - 28) 1993 Modelled IHME
21 (14 - 28) 1992 Modelled IHME
21 (14 - 28) 1991 Modelled IHME
21 (14 - 28) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
24
2019
(17 - 35)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
55
2019
(37 - 77)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines